FOIA Number: OMB-17-0134

Trump Administration Appeals Court Decision Ordering It to Turn Over Communications with Congress About ACA Sabotage

May 30, 2019
This spring, a federal judge rejected a Trump administration argument for withholding communications about weakening the Affordable Care Act. Now the administration is appealing that decision.

Federal Judge Rejects Administration’s Argument for Withholding Communications with Congress about ACA Sabotage

April 2, 2019
In a major win for transparency, a federal judge rejected an argument the administration was using to withhold communications about executive branch options for weakening the Affordable Care Act.

OMB Reply Withholding Communications Related to the ACA

February 15, 2018
Final response from OMB to our FOIA request for communications with Congress regarding the Affordable Care Act. OMB states that it reviewed all remaining potentially responsive documents and identified 9 responsive pages, which it is withholding in full pursuant to (b)(5).

OMB ACA Response

December 19, 2017
Response to our FOIA for communications with Congress regarding the Affordable Care Act.

American Oversight Sues HHS and OMB For Secret Trump Letter Outlining Plan to Weaken Obamacare

July 20, 2017
With the Trump administration’s health care reform efforts stalled yet again, American Oversight today sued to force the release of a March letter from President Trump to House Republicans detailing potential administrative options he could use to undermine the Affordable Care Act (ACA).

Complaint: American Oversight v. HHS and OMB – Sabotage Memo

July 20, 2017
Complaint against HHS and OMB seeking copy of any memo sent from the administration to Congressional Republicans regarding potential regulatory actions related to the Affordable Care Act. Concerns FOIAs HHS-17-0133 and HHS-17-0134.

FOIA Request to OMB Any Memo Sent to Congressional Republicans About Affordable Care Act

May 4, 2017
Copy of any memo sent from the administration to Congressional Republicans regarding potential regulatory actions related to the Affordable Care Act.